|
ZFYVE16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.7321035978598E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.42670003273105E-09 |
| Normal-vs-Stage2 |
5.69659999999361E-05 |
| Normal-vs-Stage3 |
7.02889968451359E-10 |
| Normal-vs-Stage4 |
3.61450003261155E-09 |
| Stage1-vs-Stage2 |
9.708600E-01 |
| Stage1-vs-Stage3 |
3.592300E-02 |
| Stage1-vs-Stage4 |
1.827650E-02 |
| Stage2-vs-Stage3 |
1.764220E-01 |
| Stage2-vs-Stage4 |
6.785500E-02 |
| Stage3-vs-Stage4 |
5.019800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.00649505291517E-11 |
| Normal-vs-AfricanAmerican |
5.684700E-03 |
| Normal-vs-Asian |
6.32159999999216E-05 |
| Caucasian-vs-AfricanAmerican |
2.554200E-01 |
| Caucasian-vs-Asian |
3.002800E-01 |
| AfricanAmerican-vs-Asian |
7.469400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.95299998185084E-09 |
| Normal-vs-Female |
3.07530001464329E-10 |
| Male-vs-Female |
9.625400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.77390000033873E-07 |
| Normal-vs-Age(41-60Yrs) |
1.72939995657373E-09 |
| Normal-vs-Age(61-80Yrs) |
3.54429999793737E-08 |
| Normal-vs-Age(81-100Yrs) |
3.117700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.774180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.485600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.849600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.938800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.055800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.064000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.839500E-03 |
| Classical-VS-Follicular |
4.735200E-01 |
| Classical-VS-Other |
7.905400E-01 |
| Classical-VS-Normal |
1.9233000000396E-06 |
| Tall-VS-Follicular |
1.297540E-02 |
| Tall-VS-Other |
2.650400E-01 |
| Tall-VS-Normal |
9.90500015340956E-10 |
| Follicular-VS-Other |
6.715400E-01 |
| Follicular-VS-Normal |
1.74500000005295E-06 |
| Other-VS-Normal |
1.000610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51190000519108E-08 |
| Normal-vs-N1 |
1.86329999996016E-06 |
| N0-vs-N1 |
9.152000E-01 |
|
|
